| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 10/02/1994 | CA2120302A1 Linear adhesion inhibitors |
| 10/02/1994 | CA2120301A1 Thiadiazinones |
| 10/01/1994 | CA2119730A1 Synthesis of cis-decahydroisoquinoline-3-carboxylic acids |
| 10/01/1994 | CA2102142A1 Method of inhibiting oxidants using alkylaryl polyether alcohol polymers |
| 09/29/1994 | WO1994021800A2 Protein tyrosine phosphatase ptp-s31 |
| 09/29/1994 | WO1994021781A2 Extracellular signal-regulated kinase, sequences, and methods of production and use |
| 09/29/1994 | WO1994021679A1 Inhibitor of vascular endothelial cell growth factor |
| 09/29/1994 | WO1994021674A1 Polypeptide bombesin antagonists |
| 09/29/1994 | WO1994021671A1 Adipocyte differentiation inhibitor peptide and adipocyte differentiation inhibitor containing said peptide as active ingredient |
| 09/29/1994 | WO1994021667A1 Compound for inhibiting bone resorption and accelerating osteogenesis |
| 09/29/1994 | WO1994021645A1 ENANTIOSELECTIVE SYNTHESIS OF 5,6-DIHYDRO-(S)-4-(ETHYLAMINO)-(S)-6-METHYL-4H-THIENO[2,3-b]THIOPYRAN-2-SULFONAMIDE 7,7-DIOXIDE AND RELATED COMPOUNDS |
| 09/29/1994 | WO1994021626A1 Indazole derivatives |
| 09/29/1994 | WO1994021625A1 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 09/29/1994 | WO1994021619A1 Naphthalene derivatives |
| 09/29/1994 | WO1994021618A1 Nitric 1,2-benzo-isothiazolyl-3(2h)one-1,1-dioxide esters, preparation method therefor and drugs containing same |
| 09/29/1994 | WO1994021616A1 Heterocycle-containing amidine derivatives, their preparation and use |
| 09/29/1994 | WO1994021608A1 Indoletetralins having dopaminergic activity |
| 09/29/1994 | WO1994021604A1 Prodrug derivatives of enzyme inhibitors with hydroxyl groups, methods of preparing them and their use |
| 09/29/1994 | WO1994021590A1 Phenoxyphenylacetic acid derivatives |
| 09/29/1994 | WO1994021278A1 Potassium channel blocking compounds and their use |
| 09/29/1994 | WO1994021275A1 Therapeutical compositions for use in humans, characterised by a combination of a muramyl peptide and a cytokine |
| 09/29/1994 | WO1994021266A1 The use of bisphosphonates in bone surgery |
| 09/29/1994 | WO1994021245A1 Use of carnosine or a combination with urocanic acid for treatment of photodermatoses |
| 09/29/1994 | WO1994021241A1 New use of anti-acne agents |
| 09/29/1994 | WO1994021235A1 Enhanced circulation effector composition and method |
| 09/29/1994 | WO1994015958A3 Peptide inhibitors of cell adhesion |
| 09/29/1994 | WO1994012880A3 Rxr homodimer formation and bridged bicyclic aromatic compounds and their use in modulating gene expression |
| 09/29/1994 | WO1994011522A3 Vector for the expression of therapy-relevant genes |
| 09/29/1994 | CA2158994A1 Heterocycle-containing amidine derivatives, their preparation and use |
| 09/29/1994 | CA2158939A1 Protein tyrosine phosphatase ptp-s31 |
| 09/29/1994 | CA2158352A1 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 09/29/1994 | CA2158051A1 Potassium channel blocking compounds and their use |
| 09/29/1994 | CA2157758A1 Compositions for use in human therapeutics, characterised by the association of a muramyl peptide with a cytokine |
| 09/29/1994 | CA2156839A1 Indazole derivatives |
| 09/29/1994 | CA2135921A1 Nitic 1,2-benzo-isothiazolyl-3(2h)one-1, 1-dioxide esters, preparation method therefor and drugs containing same |
| 09/28/1994 | EP0617128A1 Recombinant vaccine for porcine pleuropneumonia |
| 09/28/1994 | EP0617038A1 Preparation of carbonic anhydrase inhibitors |
| 09/28/1994 | EP0617037A1 Enantioselective synthesis of thieno(2,3-b) thiopyran-7, 7-dioxide compounds |
| 09/28/1994 | EP0617035A1 Heterotricyclic substituted phenylcyclohexanecarboxylic acid derivatives |
| 09/28/1994 | EP0617032A1 Cyanomethylpyridine derivatives as PAF antagonists and 5-lipoxygenase inhibitors |
| 09/28/1994 | EP0617030A1 Sulfonate and carbamate derivatives of 3-aroylbenzo (beta) thiophenes |
| 09/28/1994 | EP0617028A1 Enantiomers of 1-(4-chlorophenyl)phenylmethyl)-4-(4-methylphenyl)sulfonyl piperazine |
| 09/28/1994 | EP0617024A1 Pharmacological use of phthaloylhydrazide derivatives; combination and application thereof |
| 09/28/1994 | EP0617001A1 Phenoxyphenylacetic acid derivatives |
| 09/28/1994 | EP0616814A1 Compositions for controlled release of biologically active TGF - beta |
| 09/28/1994 | EP0616536A1 INHIBITING TRANSFORMING GROWTH FACTOR $g(b) TO PREVENT ACCUMULATION OF EXTRACELLULAR MATRIX |
| 09/28/1994 | EP0616493A1 Methods and compositions for reducing multi-drug resistance |
| 09/28/1994 | EP0537267B1 Autobiotics and their use in eliminating nonself cells in vivo |
| 09/28/1994 | EP0440684B1 Novel s-timolol derivative and process for its preparation |
| 09/28/1994 | CN1092775A Pharmaceuticals |
| 09/28/1994 | CN1092771A Aminomethylene substituted non-aromatic heterocycles |
| 09/28/1994 | CN1092767A Spiro piperdines and homologs promote release of growth hormone |
| 09/28/1994 | CN1092673A Brain-tonifying and kidney-nourishing oral liquid |
| 09/28/1994 | CN1092654A Use of hyaluronic acid and forms to prevent arterial restenosis |
| 09/28/1994 | CN1025999C ImidazoÛ4,5-BÙquinolinyloxyalkanoic acid amides with enhanced water solubility |
| 09/27/1994 | US5350867 Treatment of cancer |
| 09/27/1994 | US5350852 Arylalkylamines, process for preparing them and pharmaceutical compositions containing them |
| 09/27/1994 | US5350752 Hypotensive agents |
| 09/27/1994 | US5350751 Substituted imidazoles, pharmaceutical compositions containing these, and the use thereof as antagonists of angiotensin II receptors for the treatment of high blood pressure |
| 09/27/1994 | CA2119669A1 Phenylglycinamides of heterocyclically substituted phenylacetic acid derivatives |
| 09/27/1994 | CA2119090A1 Compositions for controlled release of biologically active tgf-.beta. |
| 09/27/1994 | CA1332172C 6,11-dihydro-11-(4-piperidylidene)-5h-benzo ¬5,6|cyclohepta-¬1,2-b|pyridines and compositions and methods of use |
| 09/25/1994 | CA2119692A1 Substituted pyridopyrimidines as antihypertensives |
| 09/24/1994 | CA2118831A1 Derivatives of (2-methyl-3-piridyl) cyanomethylpiperazine |
| 09/21/1994 | EP0615977A1 Spiro piperidines and homologs which promote release of growth hormone |
| 09/21/1994 | EP0615969A1 2,4-Diamino-3-hydroxycarboxylic acid derivatives |
| 09/21/1994 | EP0615751A1 Use of tachykinin antagonists in the treatment of emesis |
| 09/21/1994 | EP0615749A2 Use of NMDA antagonists for the treatment of pain |
| 09/21/1994 | EP0425565B1 Silicon compounds in bone treatment |
| 09/21/1994 | CN1092423A 6-heterocyclic-4-amino-1,2,2A,3,4,5-hexahydrobenzÛCDÙindoles for treating motion sickness and vomiting |
| 09/21/1994 | CN1092420A Chemical compounds |
| 09/21/1994 | CN1092418A Compounds |
| 09/21/1994 | CN1092410A Inhibitors of HIV protease useful for the treatment of aids |
| 09/21/1994 | CN1092409A Compounds for treating leukotriene-related diseases |
| 09/21/1994 | CN1092406A Compounds |
| 09/20/1994 | US5349070 Salicylic acid-maltol conjugates |
| 09/20/1994 | US5348978 Angiotensin converting enzyme inhibitors |
| 09/20/1994 | US5348974 Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders |
| 09/20/1994 | US5348863 Process for the enzymatic preparation of basic fibroblast growth factor |
| 09/20/1994 | US5348739 Combined anti-tumor therapy with interleukin-2 and histamine, analogs thereof or H2 -receptor agonists |
| 09/20/1994 | CA2119051A1 Phenoxyphenylacetic acid derivatives |
| 09/20/1994 | CA1332062C Sulfonamido derivatives inhibiting the aldose reductase enzyme system and pharmaceutical compositions containing them |
| 09/19/1994 | CA2119095A1 Heterotricyclically substituted phenyl-cyclohexane-carboxylic acid derivatives |
| 09/15/1994 | WO1994020615A1 Bone stimulating factor |
| 09/15/1994 | WO1994020540A1 NON-TOXIC RIBOSOME INACTIVATING PROTEINS (RIPs) WITH TWO CHAINS, PROCESS FOR THE PREPARATION THEREOF AND APPLICATIONS |
| 09/15/1994 | WO1994020532A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 09/15/1994 | WO1994020529A1 Osteogenic growth oligopeptides and pharmaceutical compositions containing them |
| 09/15/1994 | WO1994020527A1 Compositions and methods for the treatment of immunomediated inflammatory disorders |
| 09/15/1994 | WO1994020517A1 Gene transfer for treating a connective tissue of a mammalian host |
| 09/15/1994 | WO1994020495A1 Heterocyclic compounds and their preparation and use |
| 09/15/1994 | WO1994020491A1 Benzopyranes as potassium channel openers |
| 09/15/1994 | WO1994020481A1 4-amino-2-(hetero)aryl-butanamides useful as 5-ht1a-antagonists |
| 09/15/1994 | WO1994020472A1 Heterocyclic compounds, their use and preparation |
| 09/15/1994 | WO1994020465A1 Indole derivatives as antagonists of excitatory amino acids |
| 09/15/1994 | WO1994020459A2 Pyrrolo-pyridine derivatives as dopamine receptor ligands |
| 09/15/1994 | WO1994020455A1 Styryl derivatives, their preparation and use as pde-iv inhibitors |
| 09/15/1994 | WO1994020446A1 Trisubstituted phenyl derivatives as phosphodiesterase inhibitors and processes for their preparation |
| 09/15/1994 | WO1994020128A1 Therapeutic uses of bactericidal/permeability increasing protein products |
| 09/15/1994 | WO1994020112A1 Reduction of boar odor in meat |
| 09/15/1994 | WO1994020109A1 Use of 2h-1,2,4-benzothiadiazine 3(4h)-one 1,1 dioxide derivatives as non-competitive nmda receptor antagonists |